UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047563
Receipt number R000054240
Scientific Title Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males. A randomized, double-blind, placebo-controlled, crossover study.
Date of disclosure of the study information 2022/04/28
Last modified on 2022/10/21 09:10:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.

Acronym

Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.

Scientific Title

Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.

Scientific Title:Acronym

Exploratory study to examine continued effects of test food on oxygen utilization during exercise in healthy adult males.
A randomized, double-blind, placebo-controlled, crossover study.

Region

Japan


Condition

Condition

Healty subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore continued effects on oxygen utilization during exercise in healthy adult males after a single intake of placebo or test food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Oxygen uptake

Key secondary outcomes

Ventilatory equivalent for oxygen, Ventilatory equivalent, Carbon dioxide output, Ventilatory equivalent for carbon dioxide, Respiratory exchange ratio, Respiratory rate
Heart rate, Heart rate variability
Subjective exercise intensity (RPE)
Blood lactate concentration
Urinary excretion


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Single intake of test food

Interventions/Control_2

Single intake of placebo food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Male

Key inclusion criteria

1) Healthy adult males
2) Persons who are able to intake foods, beverage, placebo/test foods, collect urine and stay at rest according to the predetermined schedule

Key exclusion criteria

1) Persons whose clinical laboratory test values are judged to be ineligible for the study by the investigator.
2) Persons with or have a history of disorders of the digestive, circulatory, endocrine system, and are judged to be eligible for the study by the investigator.
3) Persons who habitually use drugs for the purpose of treating diseases, in principal.
4) Persons who use healthy food or supplement which are able to affect this study.
5) Persons with food allergies.
6) Persons who are judged to be ineligible for the study for any other reason by the investigator.

Target sample size

16


Research contact person

Name of lead principal investigator

1st name Tsubasa
Middle name
Last name Mizokami

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Saga Nutraceuticals Research Institute

Zip code

842-0195

Address

5006-5 Yoshinogari-cho Kanzaki-gun, Saga,

TEL

0952-52-1522

Email

Mizokami.Tsubasa@otsuka.jp


Public contact

Name of contact person

1st name Tsubasa
Middle name
Last name Mizokami

Organization

Otsuka Pharmaceutical Co., Ltd.

Division name

Saga Nutraceuticals Research Institute

Zip code

842-0195

Address

5006-5 Yoshinogari-cho Kanzaki-gun, Saga,

TEL

0952-52-1522

Homepage URL


Email

Mizokami.Tsubasa@otsuka.jp


Sponsor or person

Institute

Otsuka Pharmaceutical Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Otsuka Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Otsuka Pharmaceutical Co., Ltd.

Address

Shinagawa Grand Central Tower, 2-16-4, Konan, Minato-ku, Tokyo

Tel

03-6717-1499

Email

shimizu_se@otsuka.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

15

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 04 Month 28 Day

Date of IRB

2022 Year 04 Month 21 Day

Anticipated trial start date

2022 Year 06 Month 09 Day

Last follow-up date

2022 Year 09 Month 24 Day

Date of closure to data entry

2022 Year 09 Month 26 Day

Date trial data considered complete

2022 Year 09 Month 27 Day

Date analysis concluded

2022 Year 10 Month 10 Day


Other

Other related information



Management information

Registered date

2022 Year 04 Month 22 Day

Last modified on

2022 Year 10 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054240